- ABM Respiratory Care secures $20M Growth capital from Trinity Capital
ABM Respiratory Care secures $20M Growth capital from Trinity Capital
- XRlabs raises €7.48M Seed to bring AI into the operating room
XRlabs raises €7.48M Seed to bring AI into the operating room
- ZAP Surgical raises $36M to scale non-invasive brain surgery
ZAP Surgical raises $36M to scale non-invasive brain surgery
- Kalogon raises $5.75M to make sitting healthier for all
Kalogon has secured $5.75 million in new funding to accelerate global expansion of its smart seating technologies designed to reduce the health risks associated with prolonged sitting. The round was led by Enable Ventures, with participation from Florida Opportunity Fund, Castellan Group, and existi
- Nanordica Medical raises €1.6M to advance antibiotic-free wound care technology
Estonian medtech company Nanordica Medical has secured €1.6 million in funding to accelerate development of its nanotechnology-based wound care platform for chronic and infected wounds. The round was led by 2C Ventures, with participation from Specialist VC, Superangel, Amalfi, the Health Founders s
- Onkos Surgical receives FDA clearance to expand antibacterial implant technology
Onkos Surgical has received FDA 510(k) clearance to extend its NanoCept antibacterial technology to titanium implants within the ELEOS Limb Salvage System, broadening the use of its infection-resistant implant coating in complex orthopedic procedures. The clearance represents the second 510(k) autho
- Oli raises $6.5M to predict birth complications before they happen
Australian medtech startup Oli has raised $6.5 million in Series A3 funding to accelerate development of its wearable technology designed to predict birth complications before they occur. The round was backed by Scale Investors, Clare Ventures, and the University of Sydney, bringing Oli’s total priv
- Tandem expands CE-marked automated insulin delivery use to pregnancy and type 2 diabetes
Tandem Diabetes Care has received CE mark expansion in Europe for its Control-IQ+ automated insulin delivery (AID) systems, enabling use in adults with type 2 diabetes and people with type 1 diabetes during pregnancy. The approval covers the company’s t:slim X2 and Tandem Mobi insulin pumps, which a
- Carvolix secures new €10M tranche, bringing total financing to €20M
Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects continued support from existing strategic shareholders and is intended to support both commercialization and clinical development of its AI
- Tissium closes $68M financing for tissue reconstruction polymers
Tissium has raised $68 million (€60 million) through a combination of a $34 million Series D2 financing and a $34 million financing facility from the European Investment Bank (EIB). The funding comes as the company advances the commercialization of Coaptium Connect with Tissium Light, its FDA-author
- Valgen earns CE mark for mitral valve repair system
Valgen Medtech has received CE mark approval for its DragonFly transcatheter mitral valve repair system for the treatment of functional mitral regurgitation (FMR), expanding on the device’s approval for degenerative mitral regurgitation (DMR) granted in April 2025. The milestone makes DragonFly the
- AorticLab earns expanded CE mark for embolic protection device
AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is designed to be deployed in the aortic arch, where it captures debris during procedures to reduce the risk of embolic events
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
Kalogon has secured $5.75 million in new funding to accelerate global expansion of its smart seating technologies designed to reduce the health risks associated with prolonged sitting. The round was led by Enable Ventures, with participation from Florida Opportunity Fund, Castellan Group, and existi
Estonian medtech company Nanordica Medical has secured €1.6 million in funding to accelerate development of its nanotechnology-based wound care platform for chronic and infected wounds.
The round was led by 2C Ventures, with participation from Specialist VC, Superangel, Amalfi, the Health Founders sy
Onkos Surgical has received FDA 510(k) clearance to extend its NanoCept antibacterial technology to titanium implants within the ELEOS Limb Salvage System, broadening the use of its infection-resistant implant coating in complex orthopedic procedures.
The clearance represents the second 510(k) author
Australian medtech startup Oli has raised $6.5 million in Series A3 funding to accelerate development of its wearable technology designed to predict birth complications before they occur.
The round was backed by Scale Investors, Clare Ventures, and the University of Sydney, bringing Oli’s total priva
Tandem Diabetes Care has received CE mark expansion in Europe for its Control-IQ+ automated insulin delivery (AID) systems, enabling use in adults with type 2 diabetes and people with type 1 diabetes during pregnancy.
The approval covers the company’s t:slim X2 and Tandem Mobi insulin pumps, which au
Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects continued support from existing strategic shareholders and is intended to support both commercialization and clinical development of its AI
Tissium has raised $68 million (€60 million) through a combination of a $34 million Series D2 financing and a $34 million financing facility from the European Investment Bank (EIB).
The funding comes as the company advances the commercialization of Coaptium Connect with Tissium Light, its FDA-authori
Valgen Medtech has received CE mark approval for its DragonFly transcatheter mitral valve repair system for the treatment of functional mitral regurgitation (FMR), expanding on the device’s approval for degenerative mitral regurgitation (DMR) granted in April 2025.
The milestone makes DragonFly the f
AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI.
The device is designed to be deployed in the aortic arch, where it captures debris during procedures to reduce the risk of embolic events a